Baxter International Stock Hits Day Low of $18.44 Amid Price Pressure

Baxter International, Inc. experienced significant volatility on October 30, 2025, with the stock hitting an intraday low of USD 18.44. The company, operating within the Pharmaceuticals & Biotechnology sector, saw its stock decline by 14.54% for the day, contrasting sharply with the S&P 500, which remained unchanged.
Over the past week, Baxter's performance has been notably poor, with a 16.66% drop, and a 15.85% decline over the past month. Year-to-date, the stock has fallen by 34.29%, while its one-year performance shows a staggering decrease of 46.57%. This trend of underperformance extends over a longer horizon, with a 65.16% decline over the past three years and a 75.3% drop over the last five years.

Financial metrics indicate challenges, including a high Debt to EBITDA ratio of 3.86 times and a significant decrease in net sales, which fell by 26.29% to USD 2,810 million. The company has reported negative results for three consecutive quarters, with operating cash flow at its lowest point of USD 765 million. Baxter's current market capitalization stands at USD 16,610 million, reflecting its small-cap status in the market.